Live Updates: COVID-19 Cases
  • World 11,739,167
    World
    Confirmed: 11,739,167
    Active: 4,556,643
    Recovered: 6,641,864
    Death: 540,660
  • USA 3,040,833
    USA
    Confirmed: 3,040,833
    Active: 1,582,907
    Recovered: 1,324,947
    Death: 132,979
  • Brazil 1,626,071
    Brazil
    Confirmed: 1,626,071
    Active: 581,900
    Recovered: 978,615
    Death: 65,556
  • India 720,346
    India
    Confirmed: 720,346
    Active: 260,022
    Recovered: 440,150
    Death: 20,174
  • Russia 687,862
    Russia
    Confirmed: 687,862
    Active: 223,237
    Recovered: 454,329
    Death: 10,296
  • Peru 305,703
    Peru
    Confirmed: 305,703
    Active: 97,312
    Recovered: 197,619
    Death: 10,772
  • Spain 298,869
    Spain
    Confirmed: 298,869
    Active: 270,481
    Recovered: ?
    Death: 28,388
  • Chile 298,557
    Chile
    Confirmed: 298,557
    Active: 27,802
    Recovered: 264,371
    Death: 6,384
  • UK 285,768
    UK
    Confirmed: 285,768
    Active: 241,532
    Recovered: ?
    Death: 44,236
  • Mexico 261,750
    Mexico
    Confirmed: 261,750
    Active: 70,974
    Recovered: 159,657
    Death: 31,119
  • Iran 243,051
    Iran
    Confirmed: 243,051
    Active: 27,237
    Recovered: 204,083
    Death: 11,731
  • Italy 241,819
    Italy
    Confirmed: 241,819
    Active: 14,709
    Recovered: 192,241
    Death: 34,869
  • Pakistan 231,818
    Pakistan
    Confirmed: 231,818
    Active: 95,407
    Recovered: 131,649
    Death: 4,762
  • Saudi Arabia 213,716
    Saudi Arabia
    Confirmed: 213,716
    Active: 62,114
    Recovered: 149,634
    Death: 1,968
  • Turkey 206,844
    Turkey
    Confirmed: 206,844
    Active: 18,608
    Recovered: 182,995
    Death: 5,241
  • South Africa 205,721
    South Africa
    Confirmed: 205,721
    Active: 104,563
    Recovered: 97,848
    Death: 3,310
  • Germany 198,057
    Germany
    Confirmed: 198,057
    Active: 6,765
    Recovered: 182,200
    Death: 9,092
  • France 168,335
    France
    Confirmed: 168,335
    Active: 61,107
    Recovered: 77,308
    Death: 29,920
  • Bangladesh 165,618
    Bangladesh
    Confirmed: 165,618
    Active: 87,373
    Recovered: 76,149
    Death: 2,096
  • Canada 105,935
    Canada
    Confirmed: 105,935
    Active: 27,672
    Recovered: 69,570
    Death: 8,693
  • China 83,565
    China
    Confirmed: 83,565
    Active: 403
    Recovered: 78,528
    Death: 4,634
  • Netherlands 50,657
    Netherlands
    Confirmed: 50,657
    Active: 44,529
    Recovered: ?
    Death: 6,128
  • S. Korea 13,181
    S. Korea
    Confirmed: 13,181
    Active: 982
    Recovered: 11,914
    Death: 285
  • Australia 8,586
    Australia
    Confirmed: 8,586
    Active: 1,060
    Recovered: 7,420
    Death: 106
  • New Zealand 1,534
    New Zealand
    Confirmed: 1,534
    Active: 22
    Recovered: 1,490
    Death: 22

MIT researchers develop antibody-like receptor proteins to treat COVID-19

Author at TechGenyz Science
Cytokine Storm For COVID-19
Cytokine Storm For COVID-19 Cases

A team of MIT researches has developed a specialized protein that has the ability to soak up the excessive immune response that occurs in severe cases for COVID-19.

“The idea is that they can be injected into the body and bind to the excessive cytokines as generated by the cytokine storm, removing the excessive cytokines and alleviating the symptoms from the infection,” says Rui Qing, an MIT research scientist who is one of the senior authors of the study. Shilei Hao is the lead author of the study, Shuguang Zhang is a senior author of the paper, and David Jin is also an author.

The researchers are hoping that they can start testing the proteins on human cells and in animal models of cytokine release and coronavirus infection.

Zhang began working on this project ten years ago, and it was focused on developing a modified version of membrane-embedded proteins. Jin later approached Zhang’s lab. Jin believed that proteins that mimic the cytokine receptors could help combat cytokine storms. Zhang’s team began designing proteins that could mop up the excessive cytokines in April 2019. Zhang’s team used a hydrophilic version of the protein that could travel easily through the human bloodstream. “The cytokine receptors that we designed will soak up the majority of the excessive cytokines that are released during the cytokine storm,” Jin says.

To further stabilize the proteins in the bloodstream, the team attached an antibody segment called the Fc region. The inclusion of the Fc region makes sure that they are not attacked by the immune system.

The study gained momentum post-March when the evidence began to suggest that the SARS-CoV-2 virus was inducing cytokine storms in some patients, and the receptor proteins could be of help.

“As it turns out, our research initiated in April 2019 is directly relevant to the treatment of COVID-19 infected patients,” Zhang said, “Curiosity-driven, or even proactive research often leads to preparedness, which is key to preventing future disasters.”

The team is confident that this discovery will contribute further to clinical applications in treating viral diseases.

We Are Hiring

Subscribe